Posts tagged: Roche
Friday, 14 July 2023, 9:37 am
Hacks at The Wall Street Journal landed a decent scoop overnight about Switzerland's Roche talks to buy a stomach drug from Roivant Sciences, the US-listed biotechnology group.
According to the WSJ report, Roche is looking to pay around $7 billion for drug, so no wonder Roivant's shares are up amost 16pc in the pre-market as the market capitlisation of the company is just under $9 billion...
Read more...
Monday, 3 October 2016, 1:48 pm
I have pasted a link to today's Tip TV session below for avid followers who failed to tune in for this morning's banter.
https://www.youtube.com/watch?v=Vp6YxOLwrb8
UPDATE: Apologies - in today's session I refer to the speculation around a potential bid from Roche for Illumina valuing the business at $25 billion but in fact what I meant to say was $35 billion. ..
Read more...
Thursday, 21 July 2016, 9:46 pm
I see Bloomberg was today badgering Dr Severin Schwan, the Roche chief executive, into providing a denial to my BioMarin story from a few weeks ago.
According to the Bloomberg story I read today, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are "too high" even after the recent market correction...
Read more...
Wednesday, 6 July 2016, 12:00 am
Swiss pharmaceuticals giant Roche has once again been studying a multi-billon dollar purchase of American rare disease specialist BioMarin Pharmaceutical, according to two sources familiar with the matter.
I understand that, so far, the majority of work and analysis on BioMarin has been carried out by Roche's own executives, led by Boris Zaitra, head of M&A...
Read more...